Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
ConditionCancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThomas Jefferson University
About this trial
Einstein Medical Center in Philadelphia serves a diverse group of the patient population. The majority of patients have a diverse cultural background, low literacy, and poor social-economic status. Medication adherence for chronic medical problems is in a range of 40-70%. Medication adherence among patients on oral anti-cancer therapy is not studied in detail. The main objective is to study medication adherence to oral anticancer agents in patients with low literacy and poor socio-economic status.
Eligibility criteria
Qualifiers
All patients on oral chemotherapeutic agents
Clinical diagnosis of stage IV breast cancer
Clinical diagnosis of stage III and IV colorectal cancer (not receiving concurrent radiation therapy)
Clinical diagnosis of stage IV non-small cell lung cancer
Disqualifiers
ECOG Performance Status of 3 and above
Concurrent chemo radiation
Non-English speaker
Clinical diagnosis of dementia, or otherwise unable to give informed consent.
Trial design
Treatments tested in this trial
- Intervention
Treatment groups
110 Participants
are divided into 2 treatment groupsSponsors and collaborators
Thomas Jefferson University
Lead sponsor
Merck Sharp & Dohme LLC
Collaborator
Source ClinicalTrials.gov